GlassScriptPhysician profile
Christopher Towe
NPI 1750529111
$370,130.53
in general payments reported to CMS, 2019-2025
43 companies · $64K in 2025
The $64K reported for 2025 was more than what 98% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57K · 2020: $55K · 2021: $72K · 2022: $71K · 2023: $16K · 2024: $35K · 2025: $64K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $62K · Consulting Fee: $40K · Travel and Lodging: $5,011 · Food and Beverage: $4,549 · Education: $3,225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $61,989.67 |
| Consulting Fee | $39,539.87 |
| Travel and Lodging | $5,010.92 |
| Food and Beverage | $4,548.84 |
| Education | $3,225.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $245,975.01 | 2019-2025 | Ribfix Titan, Ribfix Blu Advantage, Advantagerib |
| Atricure, INC. | $106,739.96 | 2019-2025 | Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System |
| E.R. Squibb & Sons, L.L.C. | $7,857.15 | 2019-2024 | |
| Intuitive Surgical, INC. | $1,713.89 | 2021-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,310.77 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $1,282.80 | 2021-2024 | Tagrisso |
| Arthrex, INC. | $1,219.49 | 2024-2025 | |
| Davol INC. | $743.73 | 2019-2024 | Progel Applicator Spray Tips |
| Ethicon US, LLC | $739.64 | 2019-2025 | Ethicon, Echelon Flex, Echelon; Endopath |
| Rock Medical Orthopedics, INC. | $457.56 | 2024 | |
| Boston Scientific Corporation | $246.39 | 2020-2023 | Exalt Model D |
| Procept Biorobotics Corporation | $203.82 | 2025 | |
| Bard Access Systems, INC. | $202.70 | 2019 | |
| Integra Lifesciences Corporation | $164.53 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medtronic, INC. | $153.80 | 2023-2025 | Signia, Avalus |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Towe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.